1. Home
  2. RVMD vs PAAS Comparison

RVMD vs PAAS Comparison

Compare RVMD & PAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • PAAS
  • Stock Information
  • Founded
  • RVMD 2014
  • PAAS 1994
  • Country
  • RVMD United States
  • PAAS Canada
  • Employees
  • RVMD N/A
  • PAAS N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • PAAS
  • Sector
  • RVMD Health Care
  • PAAS
  • Exchange
  • RVMD Nasdaq
  • PAAS Nasdaq
  • Market Cap
  • RVMD 8.7B
  • PAAS 8.4B
  • IPO Year
  • RVMD 2020
  • PAAS 1995
  • Fundamental
  • Price
  • RVMD $41.33
  • PAAS $24.47
  • Analyst Decision
  • RVMD Strong Buy
  • PAAS Buy
  • Analyst Count
  • RVMD 13
  • PAAS 4
  • Target Price
  • RVMD $65.15
  • PAAS $24.50
  • AVG Volume (30 Days)
  • RVMD 1.2M
  • PAAS 3.1M
  • Earning Date
  • RVMD 02-26-2025
  • PAAS 02-19-2025
  • Dividend Yield
  • RVMD N/A
  • PAAS 1.63%
  • EPS Growth
  • RVMD N/A
  • PAAS N/A
  • EPS
  • RVMD N/A
  • PAAS 0.31
  • Revenue
  • RVMD $742,000.00
  • PAAS $2,818,900,000.00
  • Revenue This Year
  • RVMD N/A
  • PAAS $24.26
  • Revenue Next Year
  • RVMD $1,855.56
  • PAAS $6.01
  • P/E Ratio
  • RVMD N/A
  • PAAS $80.04
  • Revenue Growth
  • RVMD N/A
  • PAAS 21.71
  • 52 Week Low
  • RVMD $28.95
  • PAAS $12.19
  • 52 Week High
  • RVMD $62.40
  • PAAS $26.05
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 44.66
  • PAAS 54.95
  • Support Level
  • RVMD $40.13
  • PAAS $24.07
  • Resistance Level
  • RVMD $42.68
  • PAAS $25.81
  • Average True Range (ATR)
  • RVMD 1.41
  • PAAS 0.78
  • MACD
  • RVMD 0.10
  • PAAS -0.04
  • Stochastic Oscillator
  • RVMD 26.42
  • PAAS 52.31

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About PAAS Pan American Silver Corp.

Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.

Share on Social Networks: